Table 2.
Sociodemographic characteristics and bivariate analysis of knowledge scores of participants (N = 281)
| Variable | Frequency (%) | Knowledge score (mean ± SD) | Good knowledge | P valuea | |
|---|---|---|---|---|---|
| Yes n (%) |
No n (%) |
||||
| Overall | 54.8 ± 22.7 | 53 (19) | 228 (81) | ||
| Age (mean ± SD) | 27 ± 3.8 | ||||
| Sex | |||||
| Male | 176 (62.6) | 58.3 ± 21.3 | 41 (77.4) | 135 (59.2) | 0.014 |
| Female | 105 (37.4) | 48.9 ± 23.7 | 12 (22.6) | 93 (40.8) | |
| Cadre of intern | |||||
| Doctor | 146 (52.0) | 57.1 ± 21.9 | 29 (54.7) | 117 (51.3) | 0.048 |
| Pharmacist | 65 (23.1) | 64.5 ± 17.2 | 14 (26.4) | 33 (14.5) | |
| Nurse | 47 (16.7) | 44.1 ± 25.8 | 9 (16.9) | 56 (24.6) | |
| Midwife | 23 (8.2) | 50.7 ± 15.5 | 1 (1.9) | 22 (9.7) | |
| Referral hospital | |||||
| Mulago | 83 (29.5) | 49.4 ± 21.4 | 11 (20.8) | 72 (31.6) | 0.087 |
| Kiruddu | 50 (17.8) | 62.0 ± 21.0 | 12 (22.6) | 38 (16.7) | |
| Kawempe | 38 (13.5) | 57.5 ± 20.8 | 8 (15.1) | 30 (13.2) | |
| Mbarara | 32 (11.4) | 64.1 ± 16.5 | 8 (15.1) | 24 (10.5) | |
| Mbale | 50 (17.8) | 44.0 ± 25.6 | 5 (9.4) | 45 (19.7) | |
| Gulu | 28 (9.9) | 63.1 ± 21.9 | 9 (16.9) | 19 (8.3) | |
| Prior AMR training | |||||
| Yes | 176 (62.6) | 54.2 ± 21.9 | 29 (54.7) | 147 (64.5) | 0.186 |
| No | 105 (37.4) | 55.9 ± 24.0 | 24 (45.3) | 81 (35.5) | |
| Source of information (Yes) | |||||
| UpToDate | 118 (42.0) | 54.7 ± 22.6 | 22 (41.5) | 96 (42.1) | 0.937 |
| Medscape | 164 (58.4) | 58.5 ± 22.4 | 37 (69.8) | 127 (55.7) | 0.061 |
| Hospital pharmacist | 59 (21.0) | 54.5 ± 22.7 | 9 (16.9) | 50 (21.9) | 0.426 |
| Non-infectious disease physicians | 25 (8.9) | 56.7 ± 27.2 | 7 (13.2) | 18 (7.9) | 0.221 |
| Infectious disease specialists | 50 (17.8) | 52.0 ± 26.9 | 12 (22.6) | 38 (16.7) | 0.306 |
| Medical journals | 109 (38.8) | 58.1 ± 19.6 | 20 (37.7) | 89 (39.0) | 0.861 |
| Peers (other interns) | 76 (27.1) | 55.3 ± 23.3 | 13 (24.5) | 63 (27.6) | 0.647 |
| Guidelines by professional organizations | 109 (38.8) | 52.5 ± 21.5 | 28 (52.8) | 81 (35.5) | 0.020 |
| Wikipedia | 40 (14.2) | 48.3 ± 23.5 | 3 (5.7) | 37 (16.2) | 0.050 |
| Pharmaceutical representatives | 48 (17.1) | 62.1 ± 21.6 | 13 (24.5) | 34 (14.9) | 0.091 |
| Others | 26 (9.3) | 56.4 ± 18.9 | 4 (7.5) | 22 (9.7) | 0.795 |
Bold type indicates statistical significance (P < 0.05).
a
Chi-squared or Fisher’s exact tests performed.